• Figure 1.

    SARS-CoV-2 vaccine acceptability in patients on hemodialysis

SARS-CoV-2 Vaccine Acceptability among Patients Treated by Hemodialysis

Jeffrey Silberzweig Jeffrey Silberzweig, MD, is Chief Medical Officer, The Rogosin Institute, and Associate Professor of Clinical Medicine, Weill Cornell Medicine, New York, NY, and Co-Chair of the American Society of Nephrology COVID-19 Response Team, Emergency Partnership Initiative.

Search for other papers by Jeffrey Silberzweig in
Current site
Google Scholar
PubMed
Close
Restricted access
Save